Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amicus Therapeutics, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
FOLD
Nasdaq
8731
https://www.amicusrx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2022 Earnings Call Transcript
- Mar 8th, 2023 12:00 pm
Amicus (FOLD) Q4 Earnings Miss, Galafold Sales Beat Estimates
- Mar 2nd, 2023 4:39 pm
Q4 2022 Amicus Therapeutics Inc Earnings Call
- Mar 2nd, 2023 9:28 am
Amicus Therapeutics (FOLD) Reports Q4 Loss, Tops Revenue Estimates
- Mar 1st, 2023 2:35 pm
Amicus Therapeutics Announces Full-Year 2022 Financial Results and Corporate Updates
- Mar 1st, 2023 12:00 pm
Amicus Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
- Feb 27th, 2023 12:00 pm
Amicus Therapeutics Announces Positive Long-Term Data from Phase 3 Open-label Extension Study of AT-GAA in Late-Onset Pompe Disease at the 19th Annual WORLDSymposium™ 2023
- Feb 22nd, 2023 10:00 pm
Amicus Therapeutics to Announce Full-Year 2022 Financial Results on March 1, 2023
- Feb 14th, 2023 12:00 pm
Amicus Therapeutics Announces Presentations and Posters at the 19th Annual WORLDSymposium™ 2023
- Feb 13th, 2023 12:00 pm
Swelling losses haven't held back gains for Amicus Therapeutics (NASDAQ:FOLD) shareholders since they're up 39% over 1 year
- Feb 12th, 2023 12:33 pm
Amicus Therapeutics to Present at the SVB Securities Global Biopharma Conference
- Feb 8th, 2023 12:00 pm
Strength Seen in Syros Pharmaceuticals, Inc. (SYRS): Can Its 5.4% Jump Turn into More Strength?
- Feb 1st, 2023 2:43 pm
Amicus Therapeutics Reports Preliminary 2022 Revenue and Provides 2023 Strategic Outlook
- Jan 9th, 2023 12:00 pm
Amicus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2023 12:00 pm
12 Best 52-Week High Stocks To Buy Now
- Dec 29th, 2022 2:29 am
Market Sentiment Around Loss-Making Amicus Therapeutics, Inc. (NASDAQ:FOLD)
- Dec 26th, 2022 12:57 pm
CORRECTED-UPDATE 1-EU health regulator backs Amicus therapy for muscle disorder
- Dec 16th, 2022 1:56 pm
Amicus Therapeutics Receives Positive CHMP Opinion for Pombiliti™ (cipaglucosidase alfa) for Late-Onset Pompe Disease
- Dec 16th, 2022 1:10 pm
Why Is Amicus Therapeutics (FOLD) Up 13.7% Since Last Earnings Report?
- Dec 7th, 2022 4:30 pm
Amicus Therapeutics to Present at the Stifel 2022 Healthcare Conference
- Nov 15th, 2022 12:00 pm
Scroll